Last quarter (Q ), FluoroPharma Medical's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, FluoroPharma Medical's net income was $-252.16K. See FluoroPharma Medical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 16	Dec 15	Dec 14	Dec 13	Dec 12
Total Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Expense	$ 2.20M	$ 2.20M	$ 3.19M	$ 5.17M	$ 4.36M	$ 4.15M
Operating Income	$ -2.20M	$ -2.20M	$ -3.19M	$ -5.17M	$ -4.36M	$ -4.15M
Net Non Operating Interest Income Expense	$ -1.26M	$ -1.26M	$ -873.36K	$ -104.11K	$ -51.14K	$ 767.00
Other Income Expense	$ 1.42M	$ 1.41M	$ 896.04K	$ 1.14M	$ -1.19M	$ 132.00K
Pretax Income	$ -2.05M	$ -2.05M	$ -3.16M	$ -4.13M	$ -5.61M	$ -4.02M
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -2.57M	$ -2.57M	$ -3.74M	$ -4.69M	$ -7.28M	$ -4.18M
Basic EPS	$ -0.08	$ -0.08	$ -0.12	$ -0.16	$ -0.30	$ -0.18
Diluted EPS	$ -0.09	$ -0.08	$ -0.12	$ -0.16	$ -0.30	$ -0.18
Basic Average Shares	$ 134.22M	$ 33.56M	$ 30.04M	$ 28.64M	$ 24.37M	$ 22.64M
Diluted Average Shares	$ 176.75M	$ 33.56M	$ 30.04M	$ 28.64M	$ 24.37M	$ 22.64M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 2.20M	$ 2.20M	$ 3.19M	$ 5.17M	$ 4.36M	$ 4.15M
Net Income From Continuing And Discontinued Operation	$ -2.05M	$ -2.05M	$ -3.16M	$ -4.13M	$ -5.61M	$ -4.02M
Normalized Income	$ -3.10M	$ -3.46M	$ -4.06M	$ -5.27M	$ -4.41M	$ -4.15M
Interest Expense	$ 1.26M	$ 1.26M	$ 873.36K	$ 104.13K	$ 51.35K	$ 0.00
EBIT	$ -785.40K	$ -787.89K	$ -2.29M	$ -4.03M	$ -5.56M	$ -4.02M
EBITDA	$ -741.49K	$ -743.98K	$ -2.24M	$ -3.98M	$ -5.53M	$ -3.99M

Currency in USD

FluoroPharma Medical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing